Dialysate magnesium level and blood pressure

Slides:



Advertisements
Similar presentations
Volume 54, Pages S135-S139 (December 1998)
Advertisements

RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 56, Pages S238-S241 (July 1999)
Plasma sodium and hypertension
Volume 54, Pages S86-S91 (December 1998)
Volume 82, Issue 12, Pages (December 2012)
Prof. Silvio Cavalcanti, DEIS, Silvia Cavani, Antonio Santoro 
RenaGel®, a nonabsorbed calcium- and aluminum-free phosphate binder, lowers serum phosphorus and parathyroid hormone  Eduardo A. Slatopolsky, Steven K.
Volume 61, Issue 6, Pages (June 2002)
Dieter A. Häberle, Wolfgang Biller, Takuyuki Ise, Christian J. Metz 
Volume 90, Issue 3, Pages (September 2016)
Dialysate magnesium level and blood pressure
Volume 76, Issue 10, Pages (November 2009)
Prediction of hypertension in chronic hemodialysis patients
Hemodialysis-associated hypotension as an independent risk factor for two-year mortality in hemodialysis patients  Tatsuya Shoji, Yoshiharu Tsubakihara,
Progression of diabetic nephropathy
S.G. John, N.M. Selby, C.W. McIntyre  Kidney International 
Volume 76, Issue 3, Pages (August 2009)
A new era in phosphate binder therapy: What are the options?
Volume 81, Issue 3, Pages (February 2012)
Volume 61, Issue 2, Pages (February 2002)
D. Coyne  Kidney International  Volume 69, Pages S1-S3 (May 2006)
Volume 87, Issue 2, Pages (February 2015)
Volume 61, Issue 1, Pages (January 2002)
Volume 66, Issue 1, Pages (July 2004)
Volume 91, Issue 5, Pages (May 2017)
Correction to "Prevalence of abnormal serum vitamin D, PTH, calcium, and phosphorus in patients with chronic kidney disease: results of the study to evaluate.
Volume 74, Issue 9, Pages (November 2008)
Predilution hemodiafiltration displays no hemodynamic advantage over low-flux hemodialysis under matched conditions  Nikolaos Karamperis, Erik Sloth,
Volume 62, Issue 4, Pages (October 2002)
Blood pressure targets in hemodialysis patients
Volume 59, Issue 4, Pages (April 2001)
Volume 56, Issue 4, Pages (October 1999)
Volume 84, Issue 4, Pages (October 2013)
Volume 78, Issue 8, Pages (October 2010)
Volume 76, Issue 6, Pages (September 2009)
The third World Kidney Day: Looking back and thinking forward
Effects of hemodialysis on cardiac function
Volume 61, Issue 6, Pages (June 2002)
SYMPLICITY: not all that simple
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 61, Issue 1, Pages (January 2002)
Volume 81, Issue 4, Pages (February 2012)
Volume 54, Pages S135-S139 (December 1998)
Volume 73, Issue 8, Pages (April 2008)
Circadian regulation of renal function
Volume 62, Pages S47-S52 (December 2002)
A man with a hole in his penis
Effects of lactate-buffered and lactate-free dialysate in CAVHD patients with and without liver dysfunction  Adam G. McLean, Andrew Davenport, Dominic.
Volume 62, Issue 3, Pages (September 2002)
Carmine Zoccali, Francesca Mallamaci  Kidney International 
Hemodialysis with high-calcium dialysate impairs cardiac relaxation
The course of the remnant kidney model in mice
Organ transplantation goes to the movies
Changbin Qiu, Chris Baylis  Kidney International 
Volume 63, Issue 4, Pages (April 2003)
Atherosclerotic renal artery stenosis and reconstruction
Volume 56, Pages S238-S241 (July 1999)
Clinical and biochemical correlates of starting “daily” hemodialysis
Effect of proteinuria and glomerular filtration rate on cardiovascular risk in essential hypertension  Julian Segura, Carlos Campo, Luis M. Ruilope  Kidney.
Is it the low-protein diet or simply the salt restriction?
Volume 75, Issue 1, Pages (January 2009)
Volume 62, Pages S36-S41 (December 2002)
Importance of blood pressure control in hemodialysis patient survival
Volume 68, Issue 1, Pages (July 2005)
Volume 70, Issue 5, Pages (September 2006)
Gary R. Sirken, Chetan Shah, Rasib Raja  Kidney International 
Volume 73, Issue 11, Pages (June 2008)
Antonio Piccoli, Luana Pillon  Kidney International 
Presentation transcript:

Dialysate magnesium level and blood pressure John Kyriazis, Konstantina Kalogeropoulou, Leonidas Bilirakis, Nikolaos Smirnioudis, Vasilios Pikounis, Dimitrios Stamatiadis, Ekaterini Liolia  Kidney International  Volume 66, Issue 3, Pages 1221-1231 (September 2004) DOI: 10.1111/j.1523-1755.2004.00875.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Percent changes in serum magnesium (sMg), ionized serum calcium (iCa), and serum parathormone (PTH) in the four treatment groups during hemodialysis.*P < 0.05; **P < 0.001. Kidney International 2004 66, 1221-1231DOI: (10.1111/j.1523-1755.2004.00875.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Hourly intradialytic percent changes in (A) systolic blood pressure (SBP), (B) diastolic blood pressure (DBP), (C) mean arterial pressure (MAP), (D) cardiac index (CI), (E) stroke index (SI), and (F) total peripheral resistance index (TPRI). (▵) Group I, (□) group II, (•) group III, (○) group IV. †Significant difference between group IV and group I. *Significant difference between group IV and group II. ‡Significant difference between group IV and group III. **Significant difference between group II and group III. Data points represent mean values ± SEM. Study A, N = 8. Kidney International 2004 66, 1221-1231DOI: (10.1111/j.1523-1755.2004.00875.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Hourly intradialytic percent changes in (A) systolic blood pressure (SBP), (B) diastolic blood pressure (DBP), and (C) mean arterial pressure (MAP). (□) High (0.75 mmol/L) dialysate magnesium (HdMg), (□) medium (0.5 mmol/L) dialysate magnesium (MdMg), (•) low (0.25 mmol/L) dialysate magnesium (LdMg). *Significant difference between LdMg and HdMg groups. **Significant difference between LdMg and both MdMg and HdMg groups. ‡Significant difference between HdMg and both MdMg and LdMg groups. Data points represent mean values ± SD. Study B, N = 14. Kidney International 2004 66, 1221-1231DOI: (10.1111/j.1523-1755.2004.00875.x) Copyright © 2004 International Society of Nephrology Terms and Conditions